These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 28705781)
1. Effects of Interleukin 17 on the cardiovascular system. Robert M; Miossec P Autoimmun Rev; 2017 Sep; 16(9):984-991. PubMed ID: 28705781 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-32 in chronic inflammatory conditions is associated with a higher risk of cardiovascular diseases. Damen MSMA; Popa CD; Netea MG; Dinarello CA; Joosten LAB Atherosclerosis; 2017 Sep; 264():83-91. PubMed ID: 28716457 [TBL] [Abstract][Full Text] [Related]
3. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases. Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease. Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795 [TBL] [Abstract][Full Text] [Related]
5. Macrophage Biology in Cardiovascular Diseases. Khoury MK; Yang H; Liu B Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e77-e81. PubMed ID: 33054391 [TBL] [Abstract][Full Text] [Related]
6. Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation. Santibanez JF; Bjelica S Recent Pat Anticancer Drug Discov; 2018; 13(2):133-144. PubMed ID: 29468982 [TBL] [Abstract][Full Text] [Related]
7. Proinflammatory cytokines and ageing of the cardiovascular-renal system. Smykiewicz P; Segiet A; Keag M; Żera T Mech Ageing Dev; 2018 Oct; 175():35-45. PubMed ID: 30031888 [TBL] [Abstract][Full Text] [Related]
8. Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe. Libby P; Mallat Z; Weyand C Cardiovasc Res; 2021 Nov; 117(13):2503-2505. PubMed ID: 34698765 [No Abstract] [Full Text] [Related]
9. Ultrafine carbon particle mediated cardiovascular impairment of aged spontaneously hypertensive rats. Upadhyay S; Stoeger T; George L; Schladweiler MC; Kodavanti U; Ganguly K; Schulz H Part Fibre Toxicol; 2014 Sep; 11():36. PubMed ID: 25442699 [TBL] [Abstract][Full Text] [Related]
10. Mechanotransduction, immunoregulation, and metabolic functions of CD31 in cardiovascular pathophysiology. Caligiuri G Cardiovasc Res; 2019 Jul; 115(9):1425-1434. PubMed ID: 31119265 [TBL] [Abstract][Full Text] [Related]
11. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Hot A; Miossec P Ann Rheum Dis; 2011 May; 70(5):727-32. PubMed ID: 21345813 [TBL] [Abstract][Full Text] [Related]
12. [Cardioangioimmunology: the immune implications in the principle cardiovascular pathologies]. Lissoni P; Barni S; Mauri O; Pelizzoni F; Pittalis S; Osculati G; Valagussa F G Ital Cardiol; 1991 Oct; 21(10):1139-46. PubMed ID: 1804753 [TBL] [Abstract][Full Text] [Related]
13. Neutrophils as regulators of cardiovascular inflammation. Silvestre-Roig C; Braster Q; Ortega-Gomez A; Soehnlein O Nat Rev Cardiol; 2020 Jun; 17(6):327-340. PubMed ID: 31996800 [TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-15 in cardiovascular diseases. Guo L; Liu MF; Huang JN; Li JM; Jiang J; Wang JA J Cell Mol Med; 2020 Jul; 24(13):7094-7101. PubMed ID: 32406586 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques. de Boer OJ; van der Meer JJ; Teeling P; van der Loos CM; Idu MM; van Maldegem F; Aten J; van der Wal AC J Pathol; 2010 Mar; 220(4):499-508. PubMed ID: 20020510 [TBL] [Abstract][Full Text] [Related]
16. Beyond cholesterol--inflammatory cytokines, the key mediators in atherosclerosis. Mangge H; Hubmann H; Pilz S; Schauenstein K; Renner W; März W Clin Chem Lab Med; 2004 May; 42(5):467-74. PubMed ID: 15202781 [TBL] [Abstract][Full Text] [Related]
17. Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives. Boos CJ; Lip GY Front Biosci; 2006 Jan; 11():328-36. PubMed ID: 16146734 [TBL] [Abstract][Full Text] [Related]
18. Endothelial Cells. Sturtzel C Adv Exp Med Biol; 2017; 1003():71-91. PubMed ID: 28667554 [TBL] [Abstract][Full Text] [Related]
19. Immunometabolic function of cholesterol in cardiovascular disease and beyond. Yvan-Charvet L; Bonacina F; Guinamard RR; Norata GD Cardiovasc Res; 2019 Jul; 115(9):1393-1407. PubMed ID: 31095280 [TBL] [Abstract][Full Text] [Related]
20. The Two Faces of Interleukin-17A in Atherosclerosis. Akhavanpoor M; Akhavanpoor H; Gleissner CA; Wangler S; Doesch AO; Katus HA; Erbel C Curr Drug Targets; 2017; 18(7):863-873. PubMed ID: 28034277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]